Dr. Menon handled the financing question well enough to ALMOST suggest we don't need your money, we are showing how this is going to pay off soon enough.  And how he has deep pockets imo,  "Money is not an issue."  The Aspire deal was set up to "establish a relationship there".  I hope Leo makes it to ASCO, Dr. Holden could barely contain her own enthusiasm and it showed in her speaking.  Certain parts need to be explained/expressed but at times it sounded too much like she was reading a brochure that could have just been handed out.  I didn't read all of Grateful's posts to see if he mentioned how many people were the (guessing about 6) but I hope/and would think, there will be many more at ASCO.  Keeping the audience's ears perked is key imo.  IMO the concentration should be kevetrin's and prurisol's progress and how they is expanding.  The other compounds should be very selectively mentioned and only as briefly as possible. 

Just my thoughts anyway.  Once ASCO is over and we're updated in black and white the data will speak for itself imo. Two thumbs up.